Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances
<b>Objective</b>: This survey aimed to explore knowledge and experience on novel psychoactive substances (NPS) of healthcare professionals (HCPs). The study also aimed to assess how HCPs would like to improve their knowledge of NPS. <b>Methods</b>: Seventy paper questionnaire...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/10/3/142 |
id |
doaj-a8ff4cef27d64a9bb38873c78c841527 |
---|---|
record_format |
Article |
spelling |
doaj-a8ff4cef27d64a9bb38873c78c8415272020-11-25T01:15:20ZengMDPI AGBrain Sciences2076-34252020-03-0110314210.3390/brainsci10030142brainsci10030142Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive SubstancesCamille Ramos0Amira Guirguis1Nigel Smeeton2Hadar Zaman3Anna-Marie Felice4Stephanie Bancroft5Rosalind Gittins6Gill Hawksworth7John Martin Corkery8Fabrizio Schifano9Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UKPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UKPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UKBradford School of Pharmacy & Medical Sciences, Faculty of Life Sciences, University of Bradford, Horton Road, Bradford BD7 1DP, UKCGL, St Martins House, 14 The Common, Hatfield AL10 0UR, UKLondon North West Local Pharmacy Forum (LNWLPF) of the Royal Pharmaceutical Society, Pinner, Middlesex HA5 3EP, UKHumankind, Inspiration House, Unit 22 Bowburn North Industrial Estate, Durham DH6 5PF, UKRoyal Pharmaceutical Society, 66-68 E Smithfield, Whitechapel, London E1W 1AW, UKPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UKPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK<b>Objective</b>: This survey aimed to explore knowledge and experience on novel psychoactive substances (NPS) of healthcare professionals (HCPs). The study also aimed to assess how HCPs would like to improve their knowledge of NPS. <b>Methods</b>: Seventy paper questionnaires were disseminated in 2017 within continuing education events to pharmacists, nurses and general practitioners (GPs). Additionally, 127 online surveys were completed using the Qualtrics platform by other HCPs and mental health nurses in six United Kingdom (UK) independent mental health hospitals long-stay in-patient rehabilitation services. Two educational sessions involving pharmacists and GPs were also held in late 2017 and mid-2018. Knowledge of NPS by HCPs was evaluated prior to the start of the educational events. Evaluation forms were handed out post-sessions to garner feedback, especially on areas for improvement for future sessions. Statistical analysis of data was undertaken using SPSS (V.25). <b>Results</b>: Most HCPs reported only ‘basic’ to ‘intermediate’ NPS knowledge. Substance misuse service staff felt more informed, were more often consulted and had greater confidence regarding NPS compared to hospital and primary care professionals. A negative association was found between the age of the HCP and knowledge of NPS. Most participants expressed a need for regular training and updates as insufficient NPS-related information is currently received. <b>Conclusions</b>: An improvement within the self-reported knowledge of HCPs on NPS is evident in comparison to previous studies. Continued education of HCPs on NPS is fundamental for the provision of improved harm reduction services, which can enhance overall care for NPS service users.https://www.mdpi.com/2076-3425/10/3/142novel psychoactive substancesnpshealthcare professionalsdrug educationsubstance misuseharm reduction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Camille Ramos Amira Guirguis Nigel Smeeton Hadar Zaman Anna-Marie Felice Stephanie Bancroft Rosalind Gittins Gill Hawksworth John Martin Corkery Fabrizio Schifano |
spellingShingle |
Camille Ramos Amira Guirguis Nigel Smeeton Hadar Zaman Anna-Marie Felice Stephanie Bancroft Rosalind Gittins Gill Hawksworth John Martin Corkery Fabrizio Schifano Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances Brain Sciences novel psychoactive substances nps healthcare professionals drug education substance misuse harm reduction |
author_facet |
Camille Ramos Amira Guirguis Nigel Smeeton Hadar Zaman Anna-Marie Felice Stephanie Bancroft Rosalind Gittins Gill Hawksworth John Martin Corkery Fabrizio Schifano |
author_sort |
Camille Ramos |
title |
Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances |
title_short |
Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances |
title_full |
Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances |
title_fullStr |
Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances |
title_full_unstemmed |
Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances |
title_sort |
exploring the baseline knowledge and experience of healthcare professionals in the united kingdom on novel psychoactive substances |
publisher |
MDPI AG |
series |
Brain Sciences |
issn |
2076-3425 |
publishDate |
2020-03-01 |
description |
<b>Objective</b>: This survey aimed to explore knowledge and experience on novel psychoactive substances (NPS) of healthcare professionals (HCPs). The study also aimed to assess how HCPs would like to improve their knowledge of NPS. <b>Methods</b>: Seventy paper questionnaires were disseminated in 2017 within continuing education events to pharmacists, nurses and general practitioners (GPs). Additionally, 127 online surveys were completed using the Qualtrics platform by other HCPs and mental health nurses in six United Kingdom (UK) independent mental health hospitals long-stay in-patient rehabilitation services. Two educational sessions involving pharmacists and GPs were also held in late 2017 and mid-2018. Knowledge of NPS by HCPs was evaluated prior to the start of the educational events. Evaluation forms were handed out post-sessions to garner feedback, especially on areas for improvement for future sessions. Statistical analysis of data was undertaken using SPSS (V.25). <b>Results</b>: Most HCPs reported only ‘basic’ to ‘intermediate’ NPS knowledge. Substance misuse service staff felt more informed, were more often consulted and had greater confidence regarding NPS compared to hospital and primary care professionals. A negative association was found between the age of the HCP and knowledge of NPS. Most participants expressed a need for regular training and updates as insufficient NPS-related information is currently received. <b>Conclusions</b>: An improvement within the self-reported knowledge of HCPs on NPS is evident in comparison to previous studies. Continued education of HCPs on NPS is fundamental for the provision of improved harm reduction services, which can enhance overall care for NPS service users. |
topic |
novel psychoactive substances nps healthcare professionals drug education substance misuse harm reduction |
url |
https://www.mdpi.com/2076-3425/10/3/142 |
work_keys_str_mv |
AT camilleramos exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances AT amiraguirguis exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances AT nigelsmeeton exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances AT hadarzaman exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances AT annamariefelice exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances AT stephaniebancroft exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances AT rosalindgittins exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances AT gillhawksworth exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances AT johnmartincorkery exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances AT fabrizioschifano exploringthebaselineknowledgeandexperienceofhealthcareprofessionalsintheunitedkingdomonnovelpsychoactivesubstances |
_version_ |
1725153902048837632 |